Jak2 tyrosine kinase: A true jak of all trades?

Cell Biochemistry and Biophysics

Volumn 41, Issue 2, 2004, Pages 207-231

  Sandberg, Eric M ^a   Wallace, Tiffany A ^a   Godeny, Michael D ^a   VonDerLinden, Danielle ^a   Sayeski, Peter P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Disease; Gene transcription; Jak2; Signal transduction; Tyrosine kinase

Indexed keywords

CYTOKINE; JANUS KINASE 2; LIGAND;

ANIMAL; BIOLOGICAL MODEL; CELL NUCLEUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; METABOLISM; MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; ANIMALS; CELL NUCLEUS; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; JANUS KINASE 2; LIGANDS; MICE; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 23744492766     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:41:2:207     Document Type: Review

References (165)

1. Firmbach-Kraft, I., Byers, M., Shows, T., Dalla-Favera, R., and Krolewski, J. J. (1990) Tyk2, prototype of a novel class of non-receptor tyrosine kinase genes. Oncogene 5, 1329-1336.
2. Wilks, A. F., Harpur, A. G., Kurban, R. R., Ralph, S. J., Zurcher, G., and Ziemiecki, A. (1991) Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol. Cell. Biol. 11, 2057-2065.
3. Harpur, A. G., Andres, A. C., Ziemiecki, A., Aston, R. R., and Wilks, A. F. (1992) JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 7, 1347-1353.
4. Duhe, R. J., Rui, H., Greenwood, J. D., Garvey, K., and Farrar, W. L. (1995) Cloning of the gene encoding rat JAK2, a protein tyrosine kinase. Gene 158, 281-285.
5. Kawamura, M., McVicar, D. W., Johnston, J. A., Blake, T. B., Chen, Y. Q., Lal, B. K., et al. (1994) Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc. Natl. Acad. Sci. U. S. A. 91, 6374-6378.
6. Takahashi, T. and Shirasawa, T. (1994) Molecular cloning of rat JAK3, a novel mem-ber of the JAK family of protein tyrosine kinases. FEBS Lett. 342, 124-128.
7. Rane, S. G. and Reddy, E. P. (1994) JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells. Oncogene 9, 2415-2423.
8. Oates, A. C., Brownlie, A., Pratt, S. J., Irvine, D. V, Liao, E. C., Paw, B. H., et al. (1999) Gene duplication of zebrafish JAK2 homologs is accompanied by divergent embryonic expression patterns: only jak2a is expressed during erythropoiesis. Blood 94, 2622-2636.
9. Binari, R., and Perrimon, N. (1994) Stripe-specific regulation of pair-rule genes by hopscotch, a putative Jak family tyrosine kinase in Drosophila. Genes Dev. 8, 300-312.
10. Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., et al. (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74, 227-236.
11. Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N., et al. (1993) Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244.
12. Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Cleveland, J. L., Yi, T., and Ihle, J. N. (1993) Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proc. Natl. Acad. Sci. U. S. A. 90, 8429-8433.
13. Rui, H., Kirken, R. A., and Farrar, W. L. (1994) Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269, 5364-5368.
14. Narazaki, M., Witthuhn, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihle, J. N., et al. (1994) Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. U. S. A. 91, 2285-2289.
15. Watling, D., Guschin, D., Muller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., et al. (1993) Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 366, 166-170.
16. Schindler, C., Shuai, K., Prezioso, V. R., and Darnell, J. E., Jr. (1992) Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-813.
17. Shuai, K., Schindler, C., Prezioso, V. R., and Darnell, J. E., Jr. (1992) Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258, 1808-1812.
18. Gadina, M., Hilton, D., Johnston, J. A., Morinobu, A., Lighvani, A., Zhou, Y. J., et al. (2001) Signaling by type I and II cytokine receptors: ten years after. Curr. Opin. Immunol. 13, 363-373.
19. Kisseleva, T., Bhattacharya, S., Braunstein, J., and Schindler, C. W. (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1-24.
20. Jenab, S. and Morris, P. L. (1996) Differential activation of signal transducer and activator of transcription (STAT)-3 and STAT-1 transcription factors and c-fos messenger ribonucleic acid by interleukin-6 and interferon-gamma in Sertoli cells. Endocrinology 137, 4738-4743.
21. Tanaka, N., Asao, H., Ohbo, K., Ishii, N., Takeshita, T., Nakamura, M., et al. (1994) Physical association of JAK1 and JAK2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains. Proc. Natl. Acad. Sci. U. S. A. 91, 7271-7275.
22. Takaki, S., Kanazawa, H., Shiiba, M., and Takatsu, K. (1994) A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor alpha chain and its function in IL-5-mediated growth signal transduction. Mol. Cell. Biol. 14, 7404-7413.
23. Yin, T., Yasukawa, K., Taga, T., Kishimoto, T., and Yang, Y. C. (1994) Identification of a 130-kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. Exp. Hematol. 22, 467-472.
24. Bacon, C. M., McVicar, D. W., Ortaldo, J. R., Rees, R. C., O'Shea, J. J., and Johnston, J. A. (1995) Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J. Exp. Med. 181, 399-404.
25. Quelle, F. W., Sato, N., Witthuhn, B. A., Inborn, R. C., Eder, M., Miyajima, A., et al. (1994) JAK2 associates with the beta c chain of the receptor for granulocyte macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14, 4335-4341.
26. Wang, Y. and Fuller, G. M. (1995) Interleukin-6 and ciliary neurotrophic factor trigger janus kinase activation and early gene response in rat hepatocytes. Gene 162, 285-289.
27. Shimoda, K., Iwasaki, H., Okamura, S., Ohno, Y., Kubota, A., Arima, F., et al. (1994) G-CSF induces tyrosine phosphorylation of the JAK2 protein in the human myeloid G-CSF responsive and proliferative cells, but not in mature neutrophils. Biochem. Biophys. Res. Commun. 203, 922-928.
28. Drachman, J. G., Griffin, J. D., and Kaushansky K. (1995) The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl. J. Biol. Chem. 270, 4979-4982.
29. Ghilardi, N. and Skoda, R. C. (1997) The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 11, 393-399.
30. Rodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., et al. (1998) Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93, 373-383.
31. Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J. C., Teglund, S., et al. (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93, 385-395.
32. Neubauer, H., Cumano, A., Muller, M., Wu, H., Huffstadt, U., and Pfeffer, K. (1998) Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93, 397-409.
33. Thomis, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H., and Berg, L. J. (1995) Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 270, 794-797.
34. Suzuki, K., Nakajima, H., Saito, Y., Saito, T., Leonard, W. J., and Iwamoto, I. (2000) Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice. Int. Immunol. 12, 123-132.
35. Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, H., Pircher, H., et al. (2000) Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13, 549-560.
36. Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Dighe, A. S., et al. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
37. Park, C., Li, S., Cha, E., and Schindler, C. (2000) Immune response in Stat2 knockout mice. Immunity 13, 795-804.
38. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., et al. (1997) Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U. S A. 94, 3801-3804.
39. Kaplan, M. H., Sun, Y. L., Hoey, T., and Grusby, M. J. (1996) IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382, 174-177.
40. Wu, C., Wang, X., Gadina, M., O'Shea, J. J., Presky, D. H., and Magram, J. (2000) IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 165, 6221-6228.
41. Liu, X., Robinson, G. W., Wagner, K., Garrett, L., Wynshaw-Boris, A., and Hennighausen, L. (1997) Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11, 179-186, 1997.
42. Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S. H., Ram, P. A., et al. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. U.S.A. 94, 7239-7244.
43. Teglund, S., McKay, C., Schuetz, E., van Deursen, J. M., Stravopodis, D., Wang, D., et al. (1998) Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93, 841-850.
44. Kaplan, M. H., Schindler, U., Smiley, S. T., and Grusby, M. J. (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4, 313-319.
45. Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., et al. (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
46. Heim, M. H., Kerr, I. M., Stark, G. R., and Darnell, J. E. Jr. (1995) Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267, 1347-1349.
47. Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E. Jr, and Yancopoulos, G. D. (1995) Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267, 1349-1353.
48. Frank, S. J., Gilliland, G., Kraft, A. S., and Arnold, C. S. (1994) Interaction of the growth hormone receptor cytoplasmic domain with the JAK2 tyrosine kinase. Endocrinology 135, 2228-2239.
49. VanderKuur, J. A., Wang, X., Zhang, L., Campbell, G. S., Allevato, G., Billestrup, N., et al. (1994) Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase. J. Biol. Chem. 269, 21709-21717.
50. Wen, Z., Zhong, Z., and Darnell, J. E., Jr. (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
51. Wen, Z. and Darnell, J. E., Jr. (1997) Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25, 2062-2067.
52. Rui, L., Mathews, L. S., Hotta, K., Gustafson, T. A., and Carter-Su, C. (1997) Identification of SH2-Bb as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling. Mol. Cell. Biol. 17, 6633-6644.
53. Sayeski, P. P., Ali, M. S., Safavi, A., Lyles, M., Kim, S. O., Frank, S. J., et al. (1999) A catalytically active Jak2 is required for the angiotensin II-dependent activation of Fyn. J. Biol. Chem. 274, 33131-33142.
54. Sayeski, P. P., Ali, M. S., Hawks, K., Frank, S. J., and Bernstein, K. E. (1999) The angiotensin II-dependent association of Jak2 and c-Src requires the N-terminus of Jak2 and the SH2 domain of c-Src. Circ. Res. 84, 1332-1338.
55. Chauhan, D., Kharbanda, S. M., Ogata, A., Urashima, M., Frank, D., Malik, N., et al. (1995) Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells. J. Exp. Med. 182, 1801-1806.
56. Fuhrer, D. K. and Yang, Y. C. (1996) Complex formation of JAK2 with PP2A, P13K, and Yes in response to the hematopoietic cytokine interleukin-11. Biochem. Biophys. Res. Comm. 224, 289-296.
57. Xia, K., Mukhopadhyay, N. K., Inhorn, R. C., Barber, D. L., Rose, P. E., Lee, R. S., et al. (1996) The cytokine-activated tyrosine kinase JAK2 activates Raf-1 in a p21ras-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 93, 11681-11686.
58. VanderKuur, J., Allevato, G., Billestrup, N., Norstedt, G., and Carter-Su, C. (1995) Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J. Biol. Chem. 270, 7587-7593.
59. Fuhrer, D. K., Feng, G. S., and Yang, Y. C. (1995) Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes. J. Biol. Chem. 270, 24826-24830.
60. Zhu, T., Goh, E. L., and Lobie, P. E. (1998) Growth hormone stimulates the tyrosine phosphorylation and association of p 125 focal adhesion kinase (FAK) with JAK2. Fak is not required for stat-mediated transcription. J. Biol. Chem. 273, 10682-10689.
61. Bhat, G. J., Thekkumkara, T. J., Thomas, W. G., Conrad, K. M., and Baker, K. M. (1994) Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. J. Biol. Chem. 269, 31443-31449.
62. Marrero, M. B., Schieffer, B., Paxton, W. G., Heerdt, L., Berk, B. C., Delafontaine, P., and Bernstein, K. E. (1995) Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 375, 247-250.
63. Ju, H., Venema, V. J., Liang, H., Harris, M. B., Zou, R., and Venema, R. C. (2000) Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochem. J. 351, 257-264.
64. A receptors. Biochem. Biophys. Res. Comm. 221, 62-66.
65. Lukashova, V., Chen, Z., Duhe, R. J., Rola-Pleszczynski, M., and Stankova, J. (2003) Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus. J. Immunol. 171, 3794-3800.
66. Buggy, J. J. (1998) Binding of a-melanocyte-stimulating hormone to its G protein-coupled receptor on B-lymphocytes activates the Jak/Stat pathway. Biochem. J. 331, 211-216.
67. 1 adrenergic receptor and the Jak/Stat signaling pathway in vascular smooth muscle cells. Biochem. Biophys. Res. Comm. 268, 25-30.
68. Ali, M. S., Sayeski, P. P., Dirksen, L. B., Hayzer, D. J., Marrero, M. B., and Bernstein, K. E. (1997) Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J. Biol. Chem. 272, 23382-23388.
69. Sayeski, P. P., Ali, M. S., Frank, S. J., and Bernstein, K. E. (2001) The angiotensin II-dependent nuclear translocation of Stat1 is mediated by the Jak2 protein motif 231YRFRR. J. Biol. Chem. 276, 10556-10563.
70. Ali, M. S., Sayeski, P. P., and Bernstein, K. E. (2000) Jak2 acts as both a STAT1 kinase and as a molecular bridge linking STAT1 to the angiotensin II ATI receptor. J. Biol. Chem. 275, 15586-15593.
71. Frank, S. J. (2001) Growth hormone signalling and its regulation: preventing too much of a good thing. Growth Horm. I. G. F. Res. 11, 201-212.
72. Park, O. K., Schaefer, T. S., and Nathans, D. (1996) In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc. Natl. Acad. Sci. U. S. A. 93, 13704-13708.
73. Feng, J., Witthuhn, B. A., Matsuda, T., Kohlhuber, F., Kerr, I. M., and Ihle, J. N. (1997) Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 17, 2497-2501.
74. Rui, L. and Carter-Su, C. (1999) Identification of SH2-Bb as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2. Proc. Natl. Acad. Sci. U. S. A. 96, 7172-7177.
75. Saxton, T. M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D. J., Shalaby, F., et al. (1997) Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16, 2352-2364.
76. Kim, S. O., Jiang, J., Yi, W., Feng, G. S., and Frank, S. J. (1998) Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling. J. Biol. Chem. 273, 2344-2354.
77. You, M., Yu, D. H., and Feng, G. S. (1999) Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol. Cell. Biol. 19, 2416-2424.
78. Yin, T., Shen, R., Feng, G. S., and Yang, Y. C. (1997) Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J. Biol. Chem. 272, 1032-1037.
79. Duhe, R. J. and Farrar, W. L. (1995) Characterization of active and inactive forms of the JAK2 protein-tyrosine kinase produced via the baculovirus expression vector system. J. Biol. Chem. 270, 23084-23089.
80. Zhuang, H., Patel, S. V., He, T. C., Niu, Z., and Wojchowski, D. M. (1994) Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem. Biophys. Res. Commun. 204, 278-283.
81. Zhuang, H., Patel, S. V., He, T. C., Sonsteby, S. K., Niu, Z., and Wojchowski, D. M. (1994) Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J. Biol. Chem. 269, 21411-21414.
82. Cools, J., Peeters, P., Voet, T., Aventin, A., Mecucci, C., Grandchamp, B., et al. (1999) Genomic organization of human JAK2 and mutation analysis of its JH2-domain in leukemia. Cytogenet. Cell. Genet. 85, 260-266.
83. Jiao, H., Berrada, K., Yang, W., Tabrizi, M., Platanias, L. C., and Yi, T. (1996) Direct association with and dephosphorylation of Jak2 kinase by the SH2-domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16, 6985-6992.
84. Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., et al. (1993) Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73, 1445-1454.
85. Tsui, H. W., Siminovitch, K. A., de Souza, L., and Tsui, F. W. (1993) Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4, 124-129.
86. Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., et al. (1995) A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14, 2816-2826.
87. Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., et al. (1999) The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18, 1309-1320.
88. Chung, C. D., Liao, J., Liu, B., Rao, X., Jay, P., Berta, P., et al. (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278, 1803-1805.
89. Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., and Shuai, K. (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Natl. Acad. Sci. U. S. A. 95, 10626-10631.
90. Yoshikawa, H., Matsubara, K., Qian, G. S., Jackson, P., Groopman, J. D., Mann, J. E., et al. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat. Genet. 1, 29-35.
91. Real, P. J., Sierra, A., De Juan, A., Segovia, J. C., Lopez-Vega, J. M., and Fernandez-Luna, J. L. (2002) Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 50, 7611-7618.
92. Xie, S., Lin, H., Sun, T., and Arlinghaus, R. B. (2002) Jak2 is involved in c-Myc induction by Bcr-Abl. Oncogene 47, 7137-7146.
93. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., et al. (1996) Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 379, 645-648.
94. Yamauchi, T., Yamauchi, N., Ueki, K., Sugiyama, T., Waki, H., Miki, H., et al. (2000) Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 autocrine secretion of prolactin in human breast cancer. J. Biol. Chem. 275, 33937-33944.
95. Miyamoto, N., Sugita, K., Goi, K., Inukai, T., Lijima, K., Tezuka, T., et al. (2001) The Jak2 inhibitor AG490 predominantly abrogates the growth of human B-precursor leukemic cells with 11q23 translocation or Philadelphia chromosome. Leukemia 11, 1758-1768.
96. Seki, Y., Kai, H. Shibata, R., Nagata, T., Yasukawa, H., Yosimura, A., et al. (2000) Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ. Res. 87, 12-18.
97. Kodama, H., Fukuda, K., Pan, J., Sano, M., Takahashi, T., Kato, T., et al. (2000) Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp-130-mediated cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 279, H1635-644.
98. El-Adawi, H., Deng, L., Tramontano, A., Smith, S., Mascareno, E., Ganguly, K., et al. (2003) The functional role of the JAK-STAT pathway in post-infarction remodeling. Cardiovasc. Res. 57, 129-138.
99. Mascareno, E., El-Shafei, M., Maulik, N., Sato, M., Guo, Y., Das, D. K., et al. (2001) JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion. Circulation 104, 325-329.
100. Kleinberger-Doron, N., Shelah, N., Capone, R., Gazit, A., and Levitzki, A. (1998) Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase. Exp. Cell Res. 241, 340-351.
101. Oda, Y., Renaux, B., Bjorge, J., Saifeddine, M., Fujita, D. J., and Hollenberg, M. D. (1999) cSrc is a major cytosolic tryrosine kinase in vascular tissue. Can. J. Physiol. Pharmacol. 77, 606-617.
102. Osherov, N., Gazit, A., Gilon, C., and Levitzki, A. (1993) Selective inhibition of the EGF and HER2/Neu receptors by tyrphostins. J. Biol. Chem. 268, 11134-11142.
103. Gu, Y., Zou, Y., Aikawa, R., Hayashi, D., Kudoh, S., Yamauchi, T., et al. (2001) Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes. Mol. Cell. Biochem. 223, 35-46.
104. VonDerLinden, D., Ma, X., Sandberg, E. M., Gernert, K., Bernstein, K. E., and Sayeski, P. P. (2002) Mutation of glutamic acid residue 1046 abolishes Jak2 tyrosine kinase activity. Mol. Cell. Biochem. 241, 87-94.
105. Frank, S. J., Yi, W., Zhao, Y., Goldsmith, J. F., Gilliland, G., Jiang, J., et al. (1995) Regions of the Jak2 tyrosine kinase required for coupling to the growth hormone receptor. J. Biol. Chem. 270, 14776-14785.
106. Saharinen, P., Takaluoma, K., and Silvennoinen, O. (2000) Regulation of the Jak2 tyrosine kinase by its pseudokinase domain. Mol. Cell. Biol. 20, 3387-3395.
107. Luo, H., Rose, P., Barber, D., Hanratty, W. P., Lee, S., Roberts, T. M., et al. (1997) Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways. Mol. Cell. Biol. 17, 1562-1571.
108. Lindauer, K., Loerting, T., Liedl, K. R., and Kroemer, R. T. (2001) Prediction of the structure of human Janus kinase 2 (JAK2) comprising the two carboxy-terminal domains reveals a mechanism for autoregulation. Protein Engineering 14, 27-37.
109. Chen, M., Cheng, A., Candotti, F., Zhou, Y-J., Hymel, A., Fasth, A., et al. (2000) Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains. Mol. Cell. Biol. 20, 947-956.
110. Saharinen, P. and Silvennoinen, O. (2002) The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction. J. Biol. Chem. 277, 47954-47963.
111. Saharinen, P., Vihinen, M., and Silvennoinen, O. (2003) Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain. Mol. Biol. Cell 14, 1448-1459.
112. Bernards, A. (1991) Predicted Tyk2 protein contains two tandem protein kinase domains. Oncogene 6, 1185-1187.
113. Higgins, D. G., Thompson, J. D., and Gibson, T. J. (1996) Using CLUSTAL for multiple sequence alignments. Meth. Enzymol. 266, 383-402.
114. Kampa, D. and Burnside, J. (2000) Computational and functional analysis of the putative SH2 domain in Janus kinases. Biochem. Biophys. Res. Comm. 278, 175-182.
115. Giordanetto, F. and Kroemer, R. T. (2002) Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7. Protein Engineering 15, 727-737.
116. Girault, J. A., Labesse, G., Mornon, J., and Callebaut, I. (1998) Janus kinases and focal adhesion kinases play in the 4.1 band: a superfamily of band 4.1 domains important for cell structure and signal transduction. Mol. Med. 4, 751-769.
117. Leto, T. L. and Marchesi, V. T. (1984) A structural model of human erythrocyte protein 4.1. J. Biol. Chem. 259, 4603-4608.
118. Banville, D., Ahmad, S., Stocco, R., and Shen, S. H. (1994) A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction associated guanylate kinases. J. Biol. Chem. 269, 22320-22327.
119. Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., et al. (1992) pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. U. S A. 89, 5192-5196.
120. Yonemura, S., Hirao, M., Doi, Y., Takahashi, N., Kondo, T., Tsukita, S., et al. (1998) Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J. Cell. Biol. 140, 885-895.
121. Tanner, J. W., Chen, W., Young, R. L., Longmore, G. D., and Shaw, A. S. (1995) The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J. Biol. Chem. 270, 6523-6530.
122. Zhao, Y. M., Wagner, F., Frank, S. J., and Kraft, A. S. (1995) The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte macrophage colony-stimulating factor receptor beta c chain. J. Biol. Chem. 270, 13814-13818.
123. Chen, M., Cheng, A., Chen, Y. Q., Hymel, A. Hanson, E. P., Kimmel, E., et al. (1997) The amino terminus of Jak3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals. Proc. Natl. Acad. Sci. U. S. A. 94, 6910-6915.
124. Kohlhuber, F., Rogers, N. C., Watling, D., Feng, J., Guschin, D., Briscoe, J., et al. (1997) A JAK1/JAK2 chimera can sustain alpha and gamma interferon responses. Mol. Cell. Biol. 17, 695-706.
125. Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., and Castelli, W. P. (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N. Engl. J. Med. 322, 1561-1566.
126. Zak, R. (1984) Factors controlling cardiac growth, in Growth of the Heart in Health and Disease (Zak, R., ed.), Raven, NY, pp. 165-185.
127. Casale, P. N., Devereux, R. B., Milner, M., Zullo, G., Harshueld, G. A., Pickering, T. G., et al. (1986) Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann. Intern. Med. 105, 173-178.
128. Zimmer, H. G., Kolbeck-Ruhmkorff, C., and Zierhut, W. (1995) Cardiac hypertrophy induced by alpha- and beta-adrenergic receptor stimulation. Cardioscience 6, 47-57.
129. Komuro, I., Kaida, T., Shibazaki, Y., Kurabayashi, M., Katoh, Y., Hoh, E., et al. (1990) Stretching cardiac myocytes stimulates protooncogene expression. J. Biol. Chem. 265, 3595-3598.
130. Sadoshima, J. and Izumo, S. (1993) Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of autocrine/paracrine mechanism. EMBO J. 12, 1681-1692.
131. Rozich, J. D., Barnes, M. A., Schmid, P. G., Zile, M. R., McDermott, P. J., and Cooper, G 4th. (1995) Load effects on gene expression during cardiac hypertrophy. J. Mol. Cell. Cardiol. 27, 485-499.
132. Komuro, I., Kudo, S., Yamazaki, T., Zou, Y., Shiojima, I., and Yazaki, Y. (1996) Mechanical stretch activates the stress-activated protein kinases in cardiac myocytes. FASEB J. 10, 631-636.
133. Yamaziki, T., Tobe, K., Hoh, E., Maemura, K., Kaida, T., Komuro, I., et al. (1993) Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J. Biol. Chem. 268, 12069-12076.
134. Sadoshima, J. Xu, Y., Slayter, H. S., and Izumo, S. (1993) Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75, 977-984.
135. Ito, H., Hirata, Y., Adachi, S., Tanaka, M., Tsujino, M., Koike, A., et al. (1993) Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. Circ. Res. 81, 656-663.
136. Kodama, H., Fukada, K., Pan, J., Makino, S., Baba, A., Hori, S., et al. (1997) Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in cardiomyocytes. Circ. Res. 81, 656-663.
137. Kunisada, K., Hirota, H., Fujio, Y., Matsui, H., Tani, Y., Yamauchi-Takihara, K., et al. (1996) Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Circulation 94, 2626-2632.
138. Pennica, D., Wood, W. I., and Chien, K. R. (1996) Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp130 dependent pathways. Cytokine Growth Factor Rev. 7, 81-91.
139. Pan, J., Keiichi, F., Hiroaki, K., Shinji, M., Toshiyuki, T., Motoaki, S., et al. (1997) Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ. Res. 81, 611-617.
140. Pan, J., Fukuda, K., Kodama, H., Sano, M., Takahashi, T., Makino, S., et al. (1998) Involvement of gp130-mediated signaling in pressure overload-induced activation of the JAK/STAT pathway in rodent heart. Heart Vessels 13, 199-208.
141. Pan, J., Fukudo, K., Saito, M., Matsuzaki, J., Kodama, H., Sano, M., et al. (1999) Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ. Res. 84, 1127-1136.
142. Pennica, D., King, K. L., Shaw, K. J., Luis, E., Rullamas, J., Luoh, S. M., et al. (1995) Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 92, 1142-1146.
143. Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., et al. (1995) Cardiotrophin-1: biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 270, 10915-10922.
144. Fukuzawa, J., Booz, G. W., Hunt, R. A., Shimizu, N., Karoor, V., Baker, K. M., et al. (2000) Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: an autocrine loop for hypertrophy Hypertension 35, 1191-1196.
145. Hunter, J. J. and Chien, K. R. (1999) Signaling pathways for cardiac hypertrophy and failure. N. Engl. J. Med. 341, 1276-1283.
146. Podewski, E. K., Hilfiker-Kleiner, D., Hilfiker, A., Moraweitz, H., Lichtenberg, A., Wollert, K. C., et al. (2003) Alterations in janus kinase (JAK)-signal transducers and activators of transcription (STAT) signalling in patients with end-stage dilated cardiomyopathy. Circulation 107, 798-802.
147. Murry, C. E., Jennings, R. B., and Reimer, K. A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
148. Bolli, R. (2000) The late phase of preconditioning. Circ. Res. 87, 972-983.
149. Kuzuya, T., Hoshida, S., Yamashita, N., Fuji, H., Oe, H., Hori, M., et al. (1993) Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ. Res. 72, 1293-1299.
150. Marber, M. S., Latchman, D. S., Walker, J. M., and Yellon, D. M. (1993) Cardiac stress protein elevation 24 hours after brief ischemic or heat stress is associated with resistance to myocardial infarction. Circulation 88, 1264-1272.
151. Sun, J. Z., Tang, X. L., Park, S. W., Qiu, Y., Turrens, J. F., and Bolli, R. (1996) Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J. Clin. Invest 97, 562-576.
152. Hattori, R., Maulik, N., Otani, H., Zhu, L., Cordis, G., Engelman, R. M., et al. (2001) Role of STAT3 in ischemic preconditioning. J. Mol. Cell. Cardiol. 33, 1929-1936.
153. Guo, Y., Jones, W. K., Xuan, Y. T., Tang, X. L., Bao, W., Wu, W. J., et al. (1999) The late phase of ischemic preconditioning is abrogated by targeted disruption of the iNOS gene. Proc. Natl. Acad. Sci. U. S. A. 96, 11507-11512.
154. Shinmura, K., Tang, X. L., Wang, Y., Xuan, Y. T., Liu, S. Q., Takano, H., et al. (2000) Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc. Natl. Acad. Sci. U. S A. 97, 10197-10202.
155. Shinmura, K., Bolli, R., Liu, S. Q., Tang, X. L., Kodani, E., Xuan, Y. T., et al. (2002) Aldose reductase is an obligatory mediator of the late phase of ischemic preconditioning. Circ. Res. 91, 240-246.
156. Xuan, Y. T., Guo, Y., Han, H., Zhu, Y., and Bolli, R. (2001) An essential role of the JAKSTAT pathway in ischemic preconditioning,. Proc. Natl. Acad. Sci. U. S. A. 98, 9050-9055.
157. Xuan, Y. T., Guo, Y., Zhu, Y., Han, H., Langenbach, R., Dawn, B, et al. (2003) Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J. Mol. Cell. Cardiol. 35, 525-537.
158. Harrison, D. A., Binari, R., Nahreini, T. S., Gilman, M., and Perrimon, N. (1995) Activation of a Drosophila Janus kinase (JAK) causes hematopoietic neoplasia and developmental defects. EMBO J. 14, 2857-2865.
159. Lacronique, V., Boureux, A., Valle, V. D., Poirel, H., Quang, C. T., Mauchauffe, M., et al. (1997) A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278, 1309-1312.
160. Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., et al. (1997) Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90, 2535-2540.
161. Ho, J. M., Beattie, B. K., Squire, J. A., Frank, D. A., and Barber, D. L. (1999) Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling. Blood 93, 4354-4364.
162. Lacronique, V., Boureux, A., Monni, R., Dumon, S., Mauchauffe, M., Mayeux, P., et al. (2000) Transforming properties of chimeric TEL-JAK proteins in BA/F3 cells. Blood 95, 2076-2083.
163. Carron, C., Cormier, F., Janin, A., Lacronique, V, Giovannini, M., Daniel, M. T., et al. (2000) TEL-JAK2 transgenic mice develop T-cell leukemia. Blood 95, 3891-3899.
164. Kim, S. O., Houtman, J. C., Jiang, J., Ruppert, J. M., Bertics, P. J., and Frank, S. J. (1999) Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442a fibroblasts. J. Biol. Chem. 274, 36015-36024.
165. Gao, B., Shen, X., Kunos, G., Meng, Q., Goldberg., I. D., Rosen, E. M., et al. (2001) Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells. FEBS Lett. 488, 179-184.